BAX Stock Analysis: Buy, Sell, or Hold?
BAX - Baxter International Inc.
$20.10
0.44 (2.24%)
▲
5d:
-3.41%
30d:
+5.62%
90d:
+21.01%
BUY
MODERATE Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Jul 30, 2026
Smart Money Distribution
None View Scanner →
Strength: 4.3/10
Get Alerted When BAX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: BAX shows positive signals but monitor for confirmation. Market pricing in 3.9% annual growth which appears achievable. Moderate conviction.
💡 BUY OPPORTUNITY: BAX shows positive signals but monitor for confirmation. Market pricing in 3.9% annual growth which appears achievable. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$22.32
Based on 4.5% avg growth
INTRINSIC VALUE TODAY
$13.86
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 8.9x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: BAX is currently trading at $20.10, which is considered slightly high relative to its 30-day fair value range of $18.46 to $20.21. From a valuation perspective, the stock is trading at a premium (Forward PE: 10.0) compared to its historical average (8.9). At these levels, the market is pricing in 3.9% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, BAX is in a strong downtrend. Immediate support is located at $19.36, while resistance sits at $21.30.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, BAX is in a strong downtrend. Immediate support is located at $19.36, while resistance sits at $21.30.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$18.46 -
$20.21
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
61.4%
All Signals
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($21.54)
- NEUTRAL: Market pricing in 3.9% annual earnings growth - fairly valued
Trading Range Analysis
30-Day Trading Range
$18.46 -
$20.21
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$19.36
Resistance Level
$21.30
Current Trend
Strong Downtrend
Technical data as of
Jun 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
9.99
Wall Street Target
$21.54
(+7.2%)
Revenue Growth (YoY)
2.9%
Earnings Growth (YoY)
237.9%
Profit Margin
-9.7%
Valuation Premium vs History
+3.9% premium
PE vs Historical
10.0 vs 8.9
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+3.9%
(market-implied from PE analysis)
1-Year Target
$20.88
(+4%)
2-Year Target
$21.70
(+8%)
3-Year Target
$22.54
(+12%)
3-Yr Target (if PE normalizes)
(PE: 10→9)
PE COMPRESSION
$20.09
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 5.0%)
$50.82
(+153%)
Base:
(SPY PE: 10.0, Growth: 5.0%)
$23.30
(+16%)
Bear:
(PE: 8.5, Growth: 5.0%)
$19.80
(-2%)
Share & Embed Analysis
Last updated: June 23, 2026 6:19 PM ET
Data refreshes hourly during market hours. Next update: 7:19 PM
Data refreshes hourly during market hours. Next update: 7:19 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BAX showing a specific setup today?
Insider Activity (6 Months)
4
Buys
0
Sells
+
Net
NEUTRAL
Recent Transactions
Michael T. McCaul
BUY
2026-02-17
Ro Khanna
BUY
2026-02-17
Ro Khanna
BUY
2026-01-29
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$565 | 57 HOLD |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$88 | 54 HOLD |
|
RMD
ResMed Inc |
BUY
19 analysts |
$262 | 62 BUY |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$176 | 50 HOLD |
|
COO
The Cooper Companies, Inc |
BUY
19 analysts |
$81 | 65 BUY |
Advanced BAX Option Strategies
Professional options setups generated by AI based on today's BAX price and gamma walls.
